Immunological memory is characterized by the ability to respond specifically and more rapidly upon a subsequent encounter with a pathogen or antigen. This rapid and specific memory response upon recall is the basis for vaccination. Understanding the mechanisms that regulate immune memory is critical for the rational design of vaccines. We have recently discovered that the intracellular molecule mTOR is a major regulator of memory CD8 T cell differentiation. In vivo administration of rapamycin, a specific inhibitor of mTOR, into mice infected with LCMV significantly enhanced both the quantity and the quality of the virus-specific memory CD8 T cell response. More importantly, we have shown that mTOR acts intrinsically in antigen-specific CD8 T cells to regulate memory differentiation. In this proposal we will investigate the following: 1) role of mTOR-dependent translational control in memory CD8 T cell differentiation;2) determine if autophagy regulates memory CD8 T cell differentiation;3) and investigate if we can harness the mTOR pathway to enhance memory CD8 T cell responses and anti-viral immunity after preventative and therapeutic vaccination. The experiments proposed in this grant should yield new insights into the mechanisms of memory differentiation and provide a framework for the rational design of vaccines that elicit long-term CD8 T cell protective immunity. )

Public Health Relevance

Memory CD8 T cells are an essential component of protective immunity, and generating effective memory CD8 T cell populations with large quantity and superior quality is a major goal of successful vaccines against chronic viral infections. We have found that mTORC1 regulates memory CD8 T cell development but the molecular mechanism remains unresolved. Uncovering the mechanism will not only give us a better understanding of memory T cell development but also for establishing a new and more specific molecular target for vaccine development.)

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030048-22
Application #
8423808
Study Section
Special Emphasis Panel (ZRG1-IDM-P (02))
Program Officer
Park, Eun-Chung
Project Start
1990-07-01
Project End
2016-02-29
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
22
Fiscal Year
2013
Total Cost
$451,293
Indirect Cost
$160,136
Name
Emory University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Kamphorst, Alice O; Araki, Koichi; Ahmed, Rafi (2015) Beyond adjuvants: immunomodulation strategies to enhance T cell immunity. Vaccine 33 Suppl 2:B21-8
Bally, Alexander P R; Lu, Peiyuan; Tang, Yan et al. (2015) NF-κB regulates PD-1 expression in macrophages. J Immunol 194:4545-54
Wu, Tuoqi; Wieland, Andreas; Lee, Judong et al. (2015) Cutting Edge: miR-17-92 Is Required for Both CD4 Th1 and T Follicular Helper Cell Responses during Viral Infection. J Immunol 195:2515-9
Youngblood, Ben; Hale, J Scott; Ahmed, Rafi (2015) Memory CD8 T cell transcriptional plasticity. F1000Prime Rep 7:38
Wieland, Andreas; Shashidharamurthy, Rangaiah; Kamphorst, Alice O et al. (2015) Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection. Immunity 42:367-78
Hale, J Scott; Ahmed, Rafi (2015) Memory T follicular helper CD4 T cells. Front Immunol 6:16
Penaloza-MacMaster, Pablo; Barber, Daniel L; Wherry, E John et al. (2015) Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection. Science 347:278-82
Penaloza-MacMaster, Pablo; Kamphorst, Alice O; Wieland, Andreas et al. (2014) Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med 211:1905-18
Lu, Peiyuan; Youngblood, Benjamin A; Austin, James W et al. (2014) Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J Exp Med 211:515-27
Tarbet, E Bart; Vollmer, Almut H; Hurst, Brett L et al. (2014) In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus. Arch Virol 159:1279-91

Showing the most recent 10 out of 187 publications